RE: TURNAROUND STORY14 Mar 2019 19:07
WORSE CASE
The Directors anticipate that the gross proceeds of the Financing
currently available to the Company under the Company’s reasonable
worst case working capital scenario (excluding the Initial Tranche and
£107,000 advanced against the Second Tranche), being £893,000, will
be applied as follows, in order of priority:
Costs of the preparation of this prospectus £100,000
WideCells marketing and operating costs £354,000
CellPlan platform, marketing and operating costs £219,000
Wideacademy courseware and roll-out £32,000
General working capital (including repayment of
loans)
£188,000
Total £893,000